0000890821 EX-FILING FEES Common Stock, par value $0.01 per share ("Common Stock") 0000890821 2025-12-19 2025-12-19 0000890821 1 2025-12-19 2025-12-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-8

(Form Type)

 

Enveric Biosciences, Inc.

(Exact Name of Each Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

Security

Type

 

Security

Class Title

 

Fee

Calculation

or Carry

Forward Rule

 

Amount

Registered (1)

  

Proposed

Maximum

Offering

Price Per

Unit

  

Maximum

Aggregate

Offering

Price

   Fee Rate  

Amount of

Registration

Fee

 
Equity  Common Stock, par value $0.01 per share (“Common Stock”)  Rule 457(c) and Rule 457(h)   131,110   $5.33(2)   $698,816.30    0.00013810   $96.50 
Total Offering Amounts       $698,816.30    0.00015310   $96.50 
Total Fees Previously Paid                  - 
Total Fee Offsets                  - 
Net Fee Due                 $96.50 

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the number of shares registered hereunder includes such additional number of shares of common stock, par value $0.01 per share (the “Common Stock”) of Enveric Biosciences, Inc. (the “Company”), as are required to prevent dilution resulting from a stock split, stock dividend or similar transaction.
   
(2) The offering price has been estimated solely for the purposes of the calculation of the registration fee. The offering price has been calculated in accordance with the manner described in paragraphs (c) and (h) of Rule 457 under the Securities Act and is based upon the average of high and low prices reported by the Nasdaq Capital Market on December 18, 2025, a date within five (5) business days prior to the date of the filing of this Registration Statement.